Position history for BAKER BROS. ADVISORS LP's holdings in DENALI THERAPEUTICS INC
BAKER BROS. ADVISORS LP holds 3.7M shares of DNLI (DENALI THERAPEUTICS INC), worth $61.6M as of 2025-Q4. DNLI represents 0.4% of BAKER BROS. ADVISORS LP's portfolio.
Current Value
$61.6M
Current Shares
3.7M
Total Value Change
-$25M
Total Shares Change
0
Other major holders of DNLI: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Unchanged |
| 3.7M |
0.0% |
| $61.6M |
| 0.4% |
| $16.41 |
0 |
| 2025-Q3 | Unchanged | 3.7M | 0.0% | $54.2M | 0.4% | $14.52 | 0 |
| 2025-Q2 | Unchanged | 3.7M | 0.0% | $52.2M | 0.5% | $14.10 | 0 |
| 2025-Q1 | Unchanged | 3.7M | 0.0% | $50.7M | 0.6% | $14.78 | 0 |
| 2024-Q4 | Unchanged | 3.7M | 0.0% | $76.1M | 0.8% | $20.24 | 0 |
| 2024-Q3 | Unchanged | 3.7M | 0.0% | $108.7M | 1.1% | $29.43 | 0 |
| 2024-Q2 | Unchanged | 3.7M | 0.0% | $86.6M | 1.1% | $23.22 | 0 |